Back to Search Start Over

Light-Promoted Lysosomal Escape of a Phthalocyanine and Antisense Oligonucleotide-Complexed G-Quadruplex for Dual Photodynamic and Antisense Therapy.

Authors :
Tam DY
Lau WKM
Limanto YT
Ng DKP
Source :
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 Sep 25; Vol. 7 (10), pp. 3216-3227. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Publication Year :
2024

Abstract

Combination therapy has been proven as an effective strategy for cancer treatment. To this end, we report herein a self-assembled nucleic acid-based complex for dual photodynamic and antisense therapy. It contains a nucleolin-targeting As1411-based G-quadruplex platform, a partially hybridized antisense oligonucleotide 4625, which can inhibit the antiapoptotic protein B cell lymphoma-xL inducing apoptotic cell death, and a zinc(II) phthalocyanine (ZnPc)-based photosensitizer held by noncovalent interactions. Through a series of in vitro experiments, we have demonstrated that this DNA complex can be internalized selectively to nucleolin-overexpressed MCF-7 and A549 cells through receptor-mediated endocytosis and is localized in the lysosomes. Upon light irradiation, the photosensitization of ZnPc triggers the formation of reactive oxygen species for cell killing and promotes the lysosomal escape of 4625 for antisense therapy. The combined therapeutic effect can eliminate the cancer cells effectively with a half maximal inhibitory concentration of ca. 0.5 μM.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2024 The Authors. Published by American Chemical Society.)

Details

Language :
English
ISSN :
2575-9108
Volume :
7
Issue :
10
Database :
MEDLINE
Journal :
ACS pharmacology & translational science
Publication Type :
Academic Journal
Accession number :
39416965
Full Text :
https://doi.org/10.1021/acsptsci.4c00384